Search Results - "Wittenberg, Gayle"

Refine Results
  1. 1

    Immune targets for therapeutic development in depression: towards precision medicine by Drevets, Wayne C., Wittenberg, Gayle M., Bullmore, Edward T., Manji, Husseini K.

    Published in Nature reviews. Drug discovery (01-03-2022)
    “…Over the past two decades, compelling evidence has emerged indicating that immune mechanisms can contribute to the pathogenesis of major depressive disorder…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles by Bagot, Rosemary C, Cates, Hannah M, Purushothaman, Immanuel, Vialou, Vincent, Heller, Elizabeth A, Yieh, Lynn, LaBonté, Benoit, Peña, Catherine J, Shen, Li, Wittenberg, Gayle M, Nestler, Eric J

    Published in Biological psychiatry (1969) (15-02-2017)
    “…Abstract Background Examining transcriptional regulation by antidepressants in key neural circuits implicated in depression and understanding the relation to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementia by Saadmaan, Gazi, Hall, Anette, Ngandu, Tiia, Kemppainen, Nina, Mangialasche, Francesca, Wittenberg, Gayle M., Matton, Anna, Rinne, Juha O., Kivipelto, Miia, Solomon, Alina

    Published in European journal of neurology (01-12-2024)
    “…Background and Purpose This study evaluated associations of brain amyloid with 2‐year objective and subjective cognitive measures in a trial‐ready older…”
    Get full text
    Journal Article
  9. 9

    Metabolomic biosignature differentiates melancholic depressive patients from healthy controls by Liu, Yashu, Yieh, Lynn, Yang, Tao, Drinkenburg, Wilhelmus, Peeters, Pieter, Steckler, Thomas, Narayan, Vaibhav A, Wittenberg, Gayle, Ye, Jieping

    Published in BMC genomics (23-08-2016)
    “…Major depressive disorder (MDD) is a heterogeneous disease at the level of clinical symptoms, and this heterogeneity is likely reflected at the level of…”
    Get full text
    Journal Article
  10. 10

    Clinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANES by Cepeda, M Soledad, Stang, Paul, Blacketer, Clair, Kent, Justine M, Wittenberg, Gayle M

    Published in Journal of clinical sleep medicine (15-06-2016)
    “…To assess the clinical relevance of sleep duration, hours slept were compared by health status, presence of insomnia, and presence of depression, and the…”
    Get full text
    Journal Article
  11. 11

    Malleability of Spike-Timing-Dependent Plasticity at the CA3-CA1 Synapse by Wittenberg, Gayle M, Wang, Samuel S.-H

    Published in The Journal of neuroscience (14-06-2006)
    “…The magnitude and direction of synaptic plasticity can be determined by the precise timing of presynaptic and postsynaptic action potentials on a millisecond…”
    Get full text
    Journal Article
  12. 12

    Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists by Kern, David M., Cepeda, M. Soledad, Flores, Christopher M., Wittenberg, Gayle M.

    Published in CNS drugs (01-02-2021)
    “…Background Observational data may inform novel drug development programs by identifying previously unappreciated, clinical benefits of existing drugs. Several…”
    Get full text
    Journal Article
  13. 13

    Spike timing dependent plasticity: a consequence of more fundamental learning rules by Shouval, Harel Z, Wang, Samuel S-H, Wittenberg, Gayle M

    Published in Frontiers in computational neuroscience (01-07-2010)
    “…Spike timing dependent plasticity (STDP) is a phenomenon in which the precise timing of spikes affects the sign and magnitude of changes in synaptic strength…”
    Get full text
    Journal Article
  14. 14

    Graded Bidirectional Synaptic Plasticity Is Composed of Switch-Like Unitary Events by O'Connor, Daniel H., Wittenberg, Gayle M., Samuel S.-H. Wang, Nicoll, Roger A.

    “…Biological information storage events are often rapid transitions between discrete states. In neural systems, the initiation of bidirectional plasticity by…”
    Get full text
    Journal Article
  15. 15

    Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post‐Traumatic Stress Disorder by Kern, David M., Teneralli, Rachel E., Flores, Christopher M., Wittenberg, Gayle M., Gilbert, James P., Cepeda, M. Soledad

    Published in Psychiatric research and clinical practice (01-03-2022)
    “…Objective To systematically identify novel pharmacological strategies for preventing or treating post‐traumatic stress disorder (PTSD) by leveraging…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults by Bell, J A, Kivimäki, M, Bullmore, E T, Steptoe, A, Carvalho, L A

    Published in Translational psychiatry (15-08-2017)
    “…Evidence on systemic inflammation as a risk factor for future depression is inconsistent, possibly due to a lack of regard for persistency of exposure. We…”
    Get full text
    Journal Article
  18. 18

    Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders by Sun, Yu, Narayan, Vaibhav A, Wittenberg, Gayle M

    Published in BMC pharmacology & toxicology (21-10-2016)
    “…Side effects, or the adverse effects of drugs, contain important clinical phenotypic information that may be useful in predicting novel or unknown targets of a…”
    Get full text
    Journal Article
  19. 19
  20. 20